AYTU

News Aytu outlines $6M-$7M quarterly sales and marketing spend range as EXXUA scripts rise to over 920 in April

19d ago

News Aytu BioPharma GAAP EPS of -$0.53 misses by $0.02, revenue of $12.4M beats by $0.35M

20d ago

News Aytu BioPharma outlines EXXUA launch strategy and expects breakeven at $17.3M quarterly net revenue as ADHD portfolio remains resilient

118d ago

News Aytu BioPharma GAAP EPS of -$1.05 misses by $0.45, revenue of $15.2M beats by $3.03M

118d ago

SEC filing 8-K Filing

119d ago

News Catalyst Watch: Intel earnings, drama in Davos, and the fight for Warner Bros.

137d ago

News Mid to low cap healthcare stocks with the strongest earnings momentum

137d ago